Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

genae Buys MedicSense
  • USA - English


News provided by

genae

10 Jan, 2019, 14:30 IST

Share this article

Share toX

Share this article

Share toX

ANTWERP, Belgium and TEL-AVIV, Israel, January 10, 2019 /PRNewswire/ --

genae, Experts in Value-driven Science & Technology for the Medical Industries, today announced the acquisition of MedicSense, a Clinical, Regulatory Affairs and Quality Assurance consultancy firm.

"The vast regulatory and quality assurance expertise of the MedicSense team represents a logical expansion of genae's value chain of services," said Bart Segers, CEO at genae. "Being involved in the early stages of the development process lowers the risk of potential re-engineering and accelerates the time to market, while remaining in compliance with worldwide regulatory requirements."

"Integrating MedicSense in the genae group addresses the needs of the vibrant, high-tech medical device industry and the dynamic regulatory environment," said Adi Ickowicz and Erez Adiv co-founders and CEO's at MedicSense. "This approach favors the entire service industry and represents a major advantage for the larger multi-disciplinary and more comprehensive service providers."

About genae 

genae is involved in the development of devices and therapies that change medical practice. With HQ in Antwerp, Belgium, and offices globally, genae serves a client base ranging from publicly traded, strategic players to very early start-ups.

To learn more about genae, please visit  http://www.genae.com

About MedicSense 

MedicSense specializes in developing dedicated regulatory strategies, from initial product registration to post marketing activities, to assist companies in maneuvering through the stringent and dynamic regulation environment. With a streamlined, highly focused approach, MedicSense has been assisting companies for more than 20 years to get products past regulatory hurdles with innovative and pragmatic solutions.

To learn more about MedicSense, please visit http://www.medicsense.com

Contact 
genae associates nv
Bart Segers, co-founder and CEO
+32-3-290-03-06
Justitiestraat 6B, 2018 Antwerp, Belgium
[email protected]

MedicSense Ltd.
Adi Ickowicz, co-founder and CEO
Erez Adiv, co-founder and CEO
+972-3-923-3666
14 Imber St. Kiryat Arie Petah Tikva, 4951148 Israel
[email protected]

Modal title

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.